Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ASAQ vs AL for Malaria in Cameroon
NCT04829695Phase 4Unknown
- Sponsor
- University of Yaoundé I
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of artesunate + amodiaquine in Plasmodium falciparum malaria (2 arms), sponsored by University of Yaoundé I. Primary endpoint: Number of participants with treatment success and adverse events at 28 days. Status: unknown.
02
Drugs
artesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT04829695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04829695.